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Summary SBV 
As the world´s population increases and people's living conditions are improving, 
larger areas are needed for houses as well as food production. This means that 
new areas are exploited and that people, livestock, blood sucking insects and wild 
animals are forced to live close together. In combination with the global warming, 
leading to extreme weather such as floods and storms, this allows both new and 
old pathogens to emerge. The number of "emerging infectious diseases", EIDs, 
has increased in recent years and many of them have their origin in poor, tropical 
countries. Moçambique is therefore considered to be a high risk area for EIDs.  
Schmallenberg virus, SBV, was discovered in 2011 as an "emerging infectious 
disease" in dairy cows in Germany. The virus causes fever, diarrhea and reduced 
milk production in dairy cows as well as abortions and malformations in newborn 
calves. From these cows could SBV be detected using metagenomic technique. 
When the virus was identified in cows it soon was found in other ruminants, both 
wild and domestic. Hence it is mainly in cattle, sheep and goat the virus has led to 
problems and financial losses.  
Phyelogenetic studies showed that Schmallenberg virus is an Orthobunyavirus 
from the Simbu-serogroup. The virus is transmitted by biting midges, Culicoides 
spp, and thru its vector it has spread to large parts of Europe.  
 
The study done in Moçambique includes two parts, a serological screening for 
Schmallenberg virus in cattle, goats and sheep and a metagenomic study on 
viruses in mosquitoes in the Zambezia province. The samples were prepared and 
analyzed at the lab at the University of Eduardo Mondlane (UEM), Maputo, 
Moçambique. The metagenomic study will be completed in Sweden at the State 
University of Agricultural Sciences in Uppsala.  
When screening for Schmallenberg virus an ELISA kit "ID screen Schmallenberg 
virus Competition Multi-species" was used. In the study a majority of the tested 
animals were positive. Most animals were also positive when the serum was 
diluted 1:2, 1:4 and 1:8. The largest numbers of positive animals were found 
among the cattle where 100% tested positive. Among the sheep the average 
prevalence was 63% and among the goats 84%. 
 
This is the first study on Schmallenberg virus made outside Europe. In Europe, no 
viruses cross-reacting with SBV are known and therefore this is not investigated. 
However, on the African continent, there are a large number of viruses that 
Schmallenberg virus potentially could cross-react with. Therefore, to confirm the 
positive- ELISA result further studies need to be done, isolating Schmallenberg 
virus. 
 
  
Sammanfattning  
I och med att jordens befolkning ökar och människors levnadsvillkor förbättras 
krävs större ytor för så väl bostäder som livsmedelsproduktion. Detta gör att nya 
områden exploateras och att människor, boskap, blodsugande insekter och vilda 
djur kommer att leva närmare allt varandra. I kombination med den globala 
uppvärmningen med mer extremväder, så som översvämningar och stormar, gör det 
att både nya och gamla patogener kan få stor spridning. Antalet ”emerging 
infectious diseases”, EIDs, har ökat de senaste åren och många av dem har sitt 
ursprung i fattiga, tropiska länder. Därför anses Moçambique vara ett 
högriskområde för EIDs.  
Schmallenbergvirus, SBV, upptäcktes 2011 som en ”emerging infectious disease” 
hos i mjölkkor Tyskland. Viruset gav upphov till en sjukdom med feber, diarré och 
sänkt mjölkproduktion hos mjölkkor. Från dessa kor kunde SBV detekterads med 
hjälp av metagenomisk teknik. En liten tid senare upptäcktes att viruset inte bara 
gav upphov till sjukdom hos vuxna djur utan även ledde till både aborter och 
missbildningar hos nyfödda kalvar. När viruset väl identifierats hos kor hittades det 
snart hos andra idisslare, både vilda och tama.  Men det är framför allt hos 
produktionsdjur som kor, får och getter som sjukdomen lett till problem och 
ekonomiska förluster.  
Fyelogenetiska studier visade att Schmallenbergvirus är ett orthobunyavirus 
tillhörande simbuserogruppen. Viruset sprids med svidknott, Culicoides spp., och 
har med vektorns hjälp spridit sig till stora delar av Europa.  
Studien som gjordes i Moçambique inkluderar två delar, en serologisk screening för 
Schmallenbergvirus hos nötkreatur, get och får samt en metagenomisk studie på 
virus i myggor i Zambeziaprovinsen. Proverna preparerades och analyserades på 
labbet vid Eduardo Mondlane University, Maputo, Moçambique. Den 
metagenomiska studien kommer att slutföras i Sverige på Statens 
lantbruksuniversitet i Uppsala.  
Vi serologisk undersökning med ELISA-kitet ”ID screen Schmallenberg virus 
Competition Multi-species” hade majoriteten av djuren SBV-neutraliserande 
antikroppar. De flesta djur var även positiva när serumet späddes 1:2, 1:4 och 1:8. 
Störst antal positiva djur fanns bland nötkreaturen där 100% testades positivt. 
Bland fåren var den genomsnittliga prevalensen 63% och bland getterna 84%.  
Detta är den första studie på Schmallenbergvirus som gjorts utanför Europa. I 
Europa finns inga andra virus tillhörande simbuserogruppen varför inga 
korsreagenstester är gjorda. På den Afrikanska kontinenten finns dock ett stort antal 
virus som Schmallenbergvirs kanske skulle kunna korsreagera med. För att 
fastställa ELISA-resultaten bör vidare studier göras där Schmallenbergvirs kan 
detekteras samt korsreagensstudier göras.    
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INTRODUCTION 
There are two different focus points of this project: 
 To thru a serology screening examine if the Schmallenberg virus is 
present among sheep, goat and cattle in the Zambezia province, 
Moçambique.   
 To survey the viral fauna in mosquitoes in the Zambezia province, 
Moçambique, using metagenomic techniques.    
Schmallenberg virus was first detected in 2011 as an emerging infectious disease 
among ruminants in Europe. This is the first screening for Schmallenberg virus 
outside Europe. 
Moçambique is one of the world´s assumed hotspots for emerging infectious 
disease and to survey the viriom in the area is therefore of great interest.  
 
LITERATURE REVIEW  
Schmallenberg virus 
History 
During the summer and autumn of 2011 a new disease was seen among cattle in 
Germany (HOFFMANN et al., 2012). The disease was spreading across Europe 
from areas close to the town Schmallenberg, the very same area where the 
Bluetongue virus first was found in 2008 (CONRATHS FJ et al., 2013). The 
disease was at first presented with fever and milk drop among the cows and later 
on the virus was also linked to cases presented with diarrhea, abortion and 
malformations among neonatals. When all formerly known pathogens causing 
these symptoms had been tested and dismissed, blood samples from affected cows 
were analyzed using metagenomical techniques. A previously unknown 
Bunyavirus of the genus Orthobunyavirus was found in the samples. The virus 
was very similar to viruses from the Simbu sero-group and was named 
Schmallenberg virus (SBV) after the location where it first was found 
(HOFFMANN et al., 2012). The discovery of the SBV was the first detection of a 
virus from the Simbu sero-group in Europe. Viruses from the Simbu group had 
previously been found in Africa, North and South America, Asia, Australia and 
Oceania (SAEED et al., 2001)  
 
The majority of the viruses in the Simbu sero-group have been isolated from 
vertebrate hosts as well as arthropod vectors such as midgets and mosquitoes 
(SAEED et al., 2001)  
Many of these Simbu group-viruses are known to cause congenital malformations 
in ruminants which are referred to as “arthrogryposis hydranencephaly 
syndrome”. Depending on the time of infection during the gestation the virus will 
result in abortions, stillbirths and/or congenital defects in the neonatal animals. An 
increased mortality in the dams may be seen due to difficulties during partus. 
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After the first finding of SBV in cattle, SBV-anti bodies have been found in 
ruminants (cattle, bison, sheep, goats, cervids), alpacka and dogs (SVA 2013). 
Genetic properties 
In the first phylogenetic analysis of SBV, many similarities between SBV and 
viruses in the Simbu-group of Orthobunyaviridae were seen (HOFFMANN et al., 
2013). When using electron microscope SBV also looked like a typical 
Bunyaviridae - it is a spherical, enveloped RNA-virus with a diameter of 
approximately 100 nm. Like other Orthobunyaviridae  the genome is presented as 
a negative single stranded RNA divided in to three molecules, the small (S), 
medium (M) and large (L) segment (GOLLER et al., 2012, NAKOUNE´ 
YANDOKO et al., 2007)  
 
On the surface of the SBV as well as on other Bunyaviridae there are two 
glycoproteins, Gc and Gn, encoded by the M-segment (NAKOUNE´ YANDOKO 
et al., 2007).  The M-segment also encodes a non structural protein (SAEED et 
al., 2001). Since the M segment is coding for the viral glycoproteins that 
neutralizing antibodies in the infected host are directed against, this is the segment 
with the most pressure of selection. This leads to frequent re-assortment 
procedures concerning this segment. Every member from a group of 
Orthobunyavirus is able to exchange segments between one another thru re-
assortment (CONRATHS et al., 2013). This may lead to rapid genetic change in 
existing viruses and to the emergence of new Orthobunyaviruses (YANASE et al., 
2010, TARLINTON et al., 2012).  
 
Orthobunyaviridae also have a viral RNA-polymerase complex, encoded by the 
L-segment, responsible for the viral replication and transcription that occur 
exclusively in the cytoplasm of the host cell (NAKOUNE´ YANDOKO et al., 
2007).  The nucleocapsid protein, N, as well as a non-structural protein are 
encoded by the S-segment (SAEED et al., 2001, NAKOUNE´ YANDOKO et al., 
2007, GOLLER et al., 2012). 
 
The viral RNA-polymerase lacks a proof-reading function that is present in DNA-
viruses. Due to that, point mutations will occur more frequent in RNA-viruses 
than in DNA-viruses. RNA-viruses also lack uracil-glucosylase, a repair enzyme; 
consequently the deamination of cytidine to uracil will often occur as a point 
mutation. The absence of these “security systems” leads to a great antigenic 
variation among Bunyaviruses and drive the formation of “escape mutants”. 
Bunyaviruses are also able to do re-assort the gene segment, called antigenic shift, 
by exchanging parts of their genomes during a mixed infection. This makes these 
viruses more able to avoid the immune system of the host than the common virus 
(MOUTAILLER et al., 2011, STEUKERS et al., 2012).  
 
Hoffmann et al (2012) suggested that SBV was formed due to re-assortment of 
viruses from the Simbu sero-group. In a phylogenetic analysis the most similar 
segment to the SBV S-segment was the S-segment from a Shamonda virus 
isolated from cattle in Japan. The sequence showed 97% identity (HOFFMANN 
et al., 2012). Later phylogenetic analyses conducted by YANASE et al., (2012) 
also indicated that the SBV is a re-assortant, with the M segment originating from 
Satupheri virus and the L and S segments originating from Shamonda virus 
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(YANASE et al., 2012). Due to the lack of published sequences of Shamonda 
virus segment L and M, the phylogenetics of Schmallenberg is still uncertain 
(YANASE et al., 2012, HOFFMANN et al., 2012).  
Transmission  
The SBV is assumed to be an arbovirus, a vector borne virus, and has been found 
in Culicoides midgets such as; Culicoides obsoletus-complex, Culicoides dewulfi, 
Culicoides chiopterus and Culicoides pulicaris-complex (DE REGGE et al., 
2012). Linden et al., (2012) found that midgets from Culicoides spp. had been 
able to transfer virus between and cause infection in sheep, goats, cattle, and red 
deer. Since the active vector period in Europe are spring- and summertime, the 
prevalence of Schmallenberg cases among newborns are highest in this area 
during late summer and autumn.  
 
The virus can only be transmitted between animals thru the vector or vertically 
transferred via the placenta in a pregnant animal. The fetus is most likely to 
develop clinical symptoms if the mother is infected with SBV after the formation 
of the placenta (GARIGLANY et al., 2013). However no clinical signs of 
infection are present in the fetus if the infection occurs when the immune system 
of the fetus has developed enough to control the infection (DOUCEUL V et al., 
2013).  
 
Clinical signs will be seen in the neonatal animal if the mother is infected during 
the first part of the gestation, cattle:  0 – 5 months and goat/sheep: 0 – 3 months. If 
the mother is infected at the time for the neurological differentiation and 
development in the fetus the damage will be severe (STEUKERS et al., 2012). 
Clinical signs 
The clinical signs differ between different species. Adult goats and sheep get very 
mild or clinical signs when infected by SBV, but the fetuses can get severe 
congenital malformations. In adult cows an infection with SBV is presented with 
more apparent symptoms; hyperthermia, mucous diarrhea, loss of appetite and 
milk drop – up to 50 % of the production. The viraemia of SBV is short, it only 
lasts for 2 to 6 days in cattle (HOFFMAN et al., 2012) and an adult animal usually 
recovers within a few days (STEUKERS et al., 2012). 
 
If the dam is infected during the first trimester of the gestation the virus will 
transmit to the fetus which will develop malformations. These malformations 
most frequently lead to intrauterine death and abortion or death immediately after 
birth. Common malformations due to infection with SVB are neuro-musculo-
skeletal disorder called arthrogryposis, severe torticollis, ankylosis, kyphosis, 
lordosis, scoliosis, brachygnathia inferior and neurological disorders such as 
amaurosis, ataxia and/or behavioral abnormalities – so called “dummies” 
(GARIGLANY et al., 2012).  
 
Diagnostics 
An infection with SBV can be detected in two ways, via direct or indirect 
detection of antigen. 
 
4 
 
Direct detection – detection of the pathogen: The virus is detected in blood or 
tissue by real-time PCR or virus isolation by inoculating virus in special cell 
types. Blood samples for virus detection must be taken during the acute infection, 
while there is a viremia, when clinical signs are shown. Virus can be detected in 
EDTA blood or serum. The pathogen can also be found in abortions, stillbirths, 
fetuses and in material from malformed ruminants: brain, amniotic fluid and 
placenta (EFSA 2013). 
 
Indirect detection – detection of antibodies: SBV-antibody detection by ELISA, 
indirect immuno-fluorescens or virus neutralization test. Antibodies can be 
detected in serum or EDTA blood. Samples for indirect detection can be taken 
from fetuses, stillbirths, abortions and in material from malformed ruminants: 
pericardial fluid or blood (pre-colostral), placenta and amniotic fluid (EFSA 
2013).  
 
Immunity  
It is known that animals infected with SBV will be immune to infection after 
recovery, although at this time it is not known for how long the immunity will last 
(EFSA 2013). In areas where the prevalence of SBV is high, animals probably 
will be infected on pasture before they are old enough to breed. This will lead to 
an instant increase of cases of malformed fetuses and abortions if the SBV is 
introduced to a naïve population, which will return to normal when the area 
becomes endemic.  
 
Profylaxis and treatment 
Today there is one vaccine protecting against SBV available on the market, 
Bovilis SBV, which is an inactivated vaccine developed for sheep and cattle. The 
onset of immunity is three weeks after immunization but the duration of the 
immunity is at present unknown (Mereck animal health 2013).  
 
An alternative to vaccinations is to make sure that susceptible animals are exposed 
to the virus and have developed immunity before they first are bread. This can be 
done by moving young naïve animals to SBV endemic areas. Other alternatives 
are alteration of sites and time for breeding, so that the dam is not infected during 
the first trimester of the gestation. A reduced numbers of vectors thru use of 
pesticides, drainage of wet lands, using repellents on the animals etc are also a 
way to protect animals from infection (STEUKERS et al., 2012)..   
 
At present, there are no available therapies for bunyavirus-induced diseases and 
the treatment is limited to supportive treatment of the clinical disease 
(STEUKERS et al., 2012). Although an infection with SBV is quite mild, 
particularly in sheep and goats, the result can be not, only loss of offspring but 
difficult deliveries resulting in death of the dams.      
 
Schmallenberg virus in Europe  
Since the detection of SBV in 2011 a multiple of serology screenings have been 
conducted in Europe among ruminants. Results from these surveys indicate that 
the virus epidemiology on a herd basis is that most animals in a heard, from the 
same geographic area, either will be seronegative or seropositive (ELBERS et al., 
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2012, MEROC et al., 2013). A number of 1082 sheep from 82 herds were 
sampled in Belgium from November 2011 to April 2012, 98% of the sampled 
flocks were positive. The sero-prevalence within a positive sheep herd, ranged 
from 36,7% to 96,7% with a median of 89,3% (MEROC et al., 2013). Results 
from this study indicate that the sero-prevalence of SBV-antibodies among sheep 
in Belgium is corresponding to areas where the densities of sheep are high and 
that the sero-prevalence among sheep is low in areas with low flock density 
(MEROC et al., 2013).  
 
EID – emerging infectious diseases 
Background 
The expression “Emerging infectious diseases” (EIDs) was defined by Lederberg 
et al., (1992) as “the infections that newly appear in a population, or which have 
existed but are increasing in incidence or geographic range”. Most of the EIDs 
are of minimal global impact, but some of them have had a huge impact on both 
people and animals (e.g. the avian flu – H1N1, Nipha virus and HIV/AIDS) 
(GRACE et al., 2012). When research is done on EIDs it is mainly the threat to 
the human society that is considered.   
More than two thirds of the EIDs from the last thirty years originate from animals 
(GARGANO et al., 2010), approximately 70% of these, from wildlife (JONES et 
al., 2008). The interface of wildlife in an EID, e.g. wild animals being the natural 
host or reservoir of the pathogen, makes the control and prediction of the disease 
hard (GRACE et al., 2012). Since most of the EIDs, 60, 3%, are zoonoses they are 
a threat to both human and animal health as well as to the economy. Therefore it 
is of great importance to have global surveillance and alarm systems to increase 
the possibility to react to outbreaks of an EID in an early stage (JONES et al., 
2008).  
 
Globally over 25% of the annual deaths are directly related to infectious diseases. 
The victims are mostly people in developing countries, children in particular 
(MORENS et al., 2004). In relation, less than 10% of the annual deaths in the EU 
are caused by primary infectious diseases (QUAGLIO et al., 2012).  
  
There is strong evidence of the association between EIDs and hunger, keeping of 
livestock and poverty (GRACE et al., 2012). It is also well known that other 
factors increasing the risk for EIDs, such as tropical climate, vector-borne 
diseases and wildlife transmitting zoonotic pathogens, are concentrated in 
developing countries on lower latitude rather than in richer countries further from 
the equator (JONES et al., 2008). Even so, the highest concentration of EIDs per 
area and the main hotspots for EIDs are found in the western of Europe, the 
northeastern parts of the United States, Australia and in Japan (JONES et al., 
2008). Jones et al., (2008) assumed this to be the result of a reporting bias caused 
by financial and social factors.       
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Risk factors 
To make it possible to control and prevent the emergence and re-emergence of 
diseases many researchers have tried to target the risk factors for these events. 
When trying to predict the emergence or re-emergence of a disease not only viral 
and microbial traits are of importance, but environmental and social factors should 
be considered as well (MORENS et al., 2004).  
Among the risk factors for EIDs in the human population, the ones below are ones 
most frequently listed. Most of these risk factors also apply on zoonotic pathogens 
as well as on EIDs strictly in the animal community, and should always be 
considered when the risk for an emerging disease is evaluated.  
  
 The susceptibility to infection of the host (MORENS et al., 2004). 
 Weather and natural disasters e.g. flooding, earthquakes and hurricanes. 
(MORENS et al., 2004, WEISS et al., 2004). 
 Climate – increasing global temperature, change in climate (MORENS et 
al., 2004, WEISS et al., 2004). 
 Changing of ecosystems and use of land – destruction of natural habitat 
due to farming, deforestation, hunting, keeping per animals, pastures etc. 
(MORENS et al., 2004, Desselberger et al., 2000, SANJEEV et al., 2012, 
CHUA et al., 2000). 
 Human behavior and demographics – unplanned migration from rural 
areas to urban areas and formation of peri-urban slums, change in personal 
behaviour (MORENS et al., 2004, WEISS et al., 2004, SANJEEV et al., 
2012).  
 Rapid growth of population (SANJEEV et al., 2012). 
 Increased numbers of arthropod vectors (SANJEEV et al., 2012). 
 Poverty and famine (MORENS et al., 2004). 
 Social inequality (MORENS et al., 2004). 
 Intense global trading and travel (SANJEEV et al., 2012). 
 Poor or lack of sanitations (SANJEEV et al., 2012). 
 Political ignorance, lack of political will and lack of economical resources 
(MORENS et al., 2004, WEISS et al., 2004). 
 Breakdown of public health measures or inadequate public health 
infrastructure (MORENS et al., 2004, SANJEEV et al., 2012). 
Arboviruses as EID 
Arboviruses are virus transmitted by arthropod vectors, e.g. mosquitoes, midgets 
and ticks. The vector borne viruses have great impact worldwide and are 
responsible for 22,8% of the events of emerging infectious diseases (JONES et 
al., 2008). Zoonotic agents transmitted by arthropod vectors have repeatedly been 
ranked among the EIDs of greatest importance, e.g. hantavirus pulmonary 
syndrome and arenavirus haemorrhagic fevers (Argentine, Bolivian, Venezuelan 
and Lassa haemorrhagic fevers) (MORENS et al., 2004). Many of the risk factors 
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listed above may lead to a change in numbers and exposure to arthropod vectors 
that can carry pathogens infecting humans and animals (SANJEEV et al., 2012).  
 
The factor of greatest importance to spread of arbovirus is the climate. The global 
warming leads to a higher average temperature and change in weather, e.g. 
causing flooding, which not only allows a wider spread of vectors, changes in 
vector ranges and hosts but an increase of the vector population (Hollidge et al., 
2010). For example outbreaks of Rift valley fever virus have been linked to the 
weather phenomena ENSO (El Niño–Southern Oscillation) (GRACE et al., 2012).  
GARGANO et al., (2010) listed 7 vector-specific factors that determine whether a 
vector borne pathogen has the capacity to emerge or re-emerge in an area:   
1. Presence of vector’s preferred breeding habitat at the site of pathogen’s 
origin 
2. Vector’s preferred host 
3. Efficiency of vector 
4. External incubation period 
5. Possibility for vector of surviving to the second blood meal 
6. Possibility of transovarial transmission of pathogen  
7. Ability to remain infectious during time  
Moçambique – a risk area for EIDs?  
Since the middle of the 20
th
 century the social and political situation in 
Moçambique has been unstable. A violent emancipation from the Portuguese in 
the 1970ies was directly followed by a civil war not ending until 1994. From the 
declaration of peace in 1994 to this day the political situation has been unsettled 
and a large proportion of the population is living in grave poverty. According to 
the FAO about 70 % of the population in Moçambique is living at the level of 
absolute poverty. Agriculture is the main activity in Moçambique. This engages 
about 80 % of the population, mostly dominated by breeding and herding 
livestock, keeping poultry and growing crop at a small scale (FAO 2012).  
Moçambique is situated in an area of the world that is exposed to multiple climate 
threats due to the global warming (GRACE et al., 2012). During the annual rain 
period parts of Moçambique get flooded and consequently uninhabitable, and 
some years a large amount of people are forced away from their homes. This is 
assumed to happen more frequently as the global temperature is increasing 
(GRACE et al., 2012). 
It is proven that many re-emergences or emergences of diseases have been 
catalyzed by wars, unstable political situations and natural disasters e.g. flooding 
(MORENS et al., 2004) and that it is most probably that EIDs will originate from 
areas at lower latitudes with deficient reporting (JONES et al., 2008). This makes 
Moçambique a possible hotspot for emerging diseases.   
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With a steadily growing population of more than 25 000 000 people (WHO 2013) 
the need for animal products, such as milk and meat, is increasing in 
Moçambique. With the increasing quantity of livestock, new areas are exploited 
and used for pasture and farms. This leads to new contacts and interaction 
between domestic animals, humans, wildlife and arthropod vectors. Interface like 
this is known to be one of the factors of greatest importance when diseases are 
emerging (Siembeda, et al., 2011). New contacts are also established due to 
farming, hunting, camping, deforestation and other types of change or destruction 
of habitats. This creates many new opportunities for diseases to emerge 
(DESSELBERGER 2000). 
Emerging virus surveillance and readiness 
Today the majority of the resources for surveillance of EIDs are focused to 
countries where the diseases are least likely to emerge. To be able to spot new 
diseases before they emerge at a large scale the resources for monitoring should 
be re-allocated from the low risk areas, where they are focused today, to high risk 
areas such as poor tropical countries. This would be profitable for the high risk 
countries as well as for the low risk countries (JONES et al., 2008). For an 
efficient surveillance system the key is to have early warning systems that work at 
both national levels as well on an international ones (SANJEEV et al., 2012).  
 
Active search for emerging viruses make it possible to prevent future outbreaks. 
This can for example be done thru big screenings of plants, animals and humans, 
focusing on risk groups or risk areas, using new techniques such as metagenomics 
(KING et al., 2006, DAZAK et al., 2000).  
 
Metagenomics 
Background 
Viruses can be detected and identified using many different techniques. Before the 
arrival of molecular methods, virus detection such as serology, inoculation 
studies, vaccination, electron microscopy, filtration and cell culture were used 
(MOKILII et al., 2012). Except for the traditional methods of virus detection there 
are two types of molecular methods to discover virus:  
 
 Sequence-dependent methods e.g. PCR and microarrays - which requires a 
prior knowledge of the viral DNA and RNA to detect novel virus 
(MOKILI et al., 2012).  
 Sequence-independent viral metagenomic methods – which do not require 
any prior knowledge of the virus in the sample (MOKILI et al., 2012).  
 
Viral metagenomics is unlike other methods for viral detection since no prior 
knowledge of the viral genome is required. This makes it possible to characterize 
whole viroms in a cell culture-independent and unbiased way (BLOMSTRÖM 
2011). Delwart described metegenomics in 2007 as “a conceptually related set of 
methods relies on sequence-independent amplification, subcloning and 
sequencing of purified viral nucleic acids followed by in silico searches for 
sequence similarities to known viruses”. When applied on samples collected from 
the environment or used to analyze unmanipulated biological material it is called 
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viral metagenomics. Viral metagenomics might also be used as an umbrella term 
to describe non-specific amplification and sequencing of viral DNA and RNA 
from samples where unknown viruses are suspected to be presence (DELWART 
2007).  
 
The first use of viral metagenomics was in 2002 in San Diego where the virome 
of two marine locations in the littoral zone was characterized (BREITBART et al., 
2002). Since then, many studies have been done in this field, but only a small part 
of the virom is yet detected.  
 
Viral metagenomic analysis contains these main steps:  
 
 Sample preparation – preparing of the sample by removal of 
contaminating nucleic acids, e.g. nucleic acids from the DNA or from 
bacteria, and concentration of the viral nucleic acids (DELWART 2007).  
  
 Sequence-independent amplification – multiplication of the nucleic acids 
in the sample. This shows the actual genetic viral constitution of the 
sample (DELWART 2007).     
 
 High-trough put sequencing – determination of the order of nucleotides 
within a nucleic acid molecule using data bases containing a huge amount 
of genetic information, so-called platforms. These large scale sequencing 
platforms include a variety of amplification and sequencing techniques 
and make it possible to do a large number of sequence reads. A great 
advantage with this technique is that the sequencing can be done without 
an initial cloning of the genetic material. (BLOMSTRÖM 2011).  
 
 Bioinformatics – thru in silico analyses the huge amount of data is 
assessed, comparing previously known viral sequences and “markers” to 
the sequences from the sample, aiming to find sequences from known and 
unknown viruses. This might be the hardest and most time consuming part 
of a metagenomic study (BLOMSTRÖM 2011). 
 
 Follow-up – often further characterization and isolation of the identified 
virus has to be done as well as studies on prevalence, experimental 
infections and development of diagnostic tests. The follow-up is of great 
importance to understand the importance and significance of the finding 
(BLOMSTRÖM 2011).  
Area of use 
Throughout history viruses have caused large outbreaks and pandemics with high 
economical costs as well as many deaths. To avoid this, or at least to decrease the 
impact of a highly pathogen virus in case of an emerging new disease, it is of 
great importance to discover, characterize and identify it fast (GRENINGER et 
al., 2010).  
 
Ever since the first virus was discovered, tools for identification and detection 
have been evolving. With the sequence-independent techniques of today it is 
possible to characterize whole viral communities e.g. from seawater samples 
(BREIBART et al., 2002), samples from the gastrointestinal tract (ALLANDER 
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et al., 2007) as well as to characterize pandemics rapidly (GRENINGER et al., 
2010).  
 
Viruses are known to be important sources of EIDs both in animals and in 
humans. Preventively screenings and early detection using are the keys in an 
effective prevention from emerging infectious diseases (CLEAVELAND et al., 
2001). This is a good application for the use of viral metagenomics.  
 
The main advantage of using viral metagenomic techniques is its unbiased way to 
rapidly identify novel viruses (DELWART 2007). Hopefully the future will 
provide better methods to separate viral and host DNA/RNA as well as developed 
bioinformatics.  
 
According this, metagenomic techniques, are an optimal way to survey the viriom 
in mosquitoes in the Zambezia province.   
MATERIAL AND METHODS 
Collection of samples 
The sample collection was done in the Zambezia province in Moçambique during 
two weeks in September 2013. Blood were taken from the jugular vein from 86 
cows, 402 sheep and 336 goats. The blood was collected using a vacutainer 
system and serum tubes. When separated from the whole-blood, the serum was 
transferred into micro tubes containing about 2 ml each. The blood and serum 
were kept in a cooling box with ice during transportation and in a refrigerator at   
    in the lab.  
For the SBV screening adult females were chosen for the serology since they were 
in majority as well as the oldest animals. Therefore they were the ones were the 
most likely to be exposed to the virus. Table 1, table 2 and table 3 are presenting 
the sampled numbers of animals and coordinates for the farms for cattle, sheep 
and goats respectively.  
Tabell 1 
Species Farm Coordinates Samples 
Bos 
indicus 
Cuacua - 
Rogerio 
 
S: 17.80069 
E:035.41220 
36 
Bos 
indicus 
Nicoadala 
- Amed 
 
S: 17.60421 
E:036.82723 
49 
Table 1 is presenting the farm’s coordinates and the number of sampled cattle on 
each farm.  
Tabell 2 
Species Farm Coordinat
es 
Sampl
es 
Sheep Cuácua - S:  98 
11 
 
Rogerio 
 
17.79748 
E:035.4144
2 
Sheep Mopeia 
south 
 
 
S: 17.84602 
E: 035.74150 
 
 
55 
Sheep  Nicuad
ala - 
Mucelo 
 
 
S: 17.70626 
E: 
036.89647 
196 
Sheep Quelim
ane - 
Padeiro 
 
S: 17.82279 
E: 036.92272 
 
44 
Sheep Nicuad
ala - 
Amed 
 
S: 17.60421 
E: 
036.82723 
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Table 2 is presenting the farm’s coordinates and the number of sampled sheep on 
each farm.  
Tabell 3 
Species Farm Coordinat
es 
Sampl
es 
Goat  Cuacua - 
Rogerio 
 
 
S: 17.79748 
E: 
035.41442 
9 
Goat Deda 
 
 
S: 17.98278 
E: 
035.76248 
5 
Goat Quelimane 
- Padeiro 
 
 
S: 17.82279 
E. 
036.92272 
36 
Goat Nicuadala 
- Amed 
 
 
S: 17.60097 
E:036.8293
2 
104 
Goat Nicuadala 
- Mingano 
 
 
S: 17.80573 
E: 
037.13612 
38 
Goat Quelimane 
- Dona ana 
 
 
S: 17.83348 
E: 
036.93911 
63 
Table 3 is presenting the farm’s coordinates and the number of sampled goats on 
each farm.  
Mosquitoes were collected in the area of Cuacua-Rogerio (S: 17.80069 E: 
035. 1220) using WHO’s light trap, originally designed to trap mosquitoes from 
the genus Anopheles. The traps were placed shielded from wind directly adjacent 
to the animal’s night time shelter. A picture of the trap is to be seen below in 
figure 2. The traps were used for 5 nights. In table 4 the number of collected 
mosquitoes from each species on the particular dates is on display.     
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Tabell 4 
Date Site Coordinates Light trap Anopheles Culex Monsonia Outros Total 
2013-09-
25 
Cuacua 
Lodge 
S: 17 79 748; E 
03541442 
Trap 1 46 105 62 33 246 
2013-09-
26 
Cuacua 
Lodge 
S: 17 79 748; E 
03541443 
 Trap 1 25 19 66 0 110 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541444 
Trap 2  2 98 77 0 177 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541445 
Trap 3 6 59 31 0 96 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541446 
Trap 4 65 700 107 0 872 
2013-09-
27 
Cuacua 
Lodge 
S: 17 79 748; E 
03541447 
Trap 1 8 70 39 0 117 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541448 
Trap 2 166 1365 778 0 2309 
2013-09-
28 
Cuacua 
Lodge 
S: 17 79 748; E 
03541449 
Trap 1 12 500 100 0 612 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541450 
Trap 2 15 50 400 0 465 
 Cuacua 
Lodge 
S: 17 79 748; E 
03541451 
Trap 3 2 40 25 0 67 
Total    347 3006 1685 33 5071 
Table 4 shows the exact number and site of the collected mosquitoes.  
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Figure 2 shows the light trap used for collecting mosquitoes.  
 
After the trapping the mosquitoes were euthanized with ether, separated according 
to genus (Culex, Monsonia and Anopheles) and put in ethanol 99,   . During the 
transportation the mosquitoes were kept in a cooling box with ice. At the lab they 
were stored in a refrigerator at      .  
Questionnaire: 
The questions were asked by Dr José Fafetine in Portuguese to the farmers/ the 
animal keepers. Their answers were translated to English by him as well.  
The asked questions were:  
 How many animals do you have? 
 Have you seen any health issues in your animals during the last year, or 
before? 
 Any abortions? 
 Any misshaped fetuses?  
 Cases of death in newborns? 
 Do you vaccinate any animals? 
Lab techniques 
The lab work was done at the veterinary faculty in Maputo, University of Eduardo 
Mondlane, Moçambique. 
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ELISA 
An ELISA-kit from ID. vet was used screen for SBV amongst sheep, goat and 
cattle in Zambezia province. The kit is called “ID screen Schmallenberg virus 
Competition Multi-species” and is developed to detect SBV antibodies in cattle, 
sheep and goat. Information about the ELISA can be found at ID vets’ website: 
www.id-vet.com.  The protocol included in the kit was followed and initially 50 
µl undiluted serum was used. The microplate was red at 450 nm. A part of the 
tested samples were re-tested in various dilutions. As dissolvent PBS, diluted 1x, 
was used. The different dilutions were: 1:2, 1:4, 1:8, 1:100, 1:200 and 1: 400.  
Metaganomics 
The samples used for metagenomic analyzes were the collected mosquitoes. The 
steps of the metagenomic analyses done in Moçambique were:  
 Sample pre-preparation 
 DNA extraction 
 DNA labelling 
 Random amplification of labelled DNA 
Due to outer circumstances such as dysfunctional pipettes and power failure the 
samples will be sent to Sweden and the remaining steps will be done there.  
Sample pre-preparation  
Since the mosquitoes were stored in ethanol they were washed in distilled water 
and dried on filter paper before further use. The mosquitoes were divided in to 5 
aliquots per genera with 20 mosquitoes in each micro tube. Then 1, 5 ml DNase 
buffer (100 U) was added to the aliquots and using an electric mortel (VWR 
International) the samples were homogenised. The homogenate was centrifuged 2 
x 5 minutes at 4000 rpm and then the supernatant was transferred to clean tubes. 
The supernatant were divided in to 4 aliquots, 2 of the volume of 200 µl for DNA 
extraction and 2 of the volume of 250 µl for RNA extraction, to which 750 µl 
Trizol was added. The RNA tubes were stored in a -80 degrees freezer until 
transported to Sweden for RNA extraction and metagenomic analyzes. To the 
D A tubes 2 g   ase A and 100   D ase I was added and then incubated in a 
37   water bath for 2 hours.  
DNA extraction 
DNA extraction was done using “QIAamp DNA mini kit” where the included 
protocol was followed exactly except from the last step, the elution. The DNA 
was eluted in 50 µl elution buffer (included in the kit).  
DNA labelling 
The D A labelling was done using a “mini cycler”. 
 
Used reagents were:  
 
 2 µl FRoV26-N (10 µM) (GCCGGAGCTCTGCAGATATCNNNNNN)  
(ALLANDER et al., 2005) 
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 1, 5 µl dNTP (10mM each) 
 1, 5 µl NEB2 buffer (10X) 
 
 10 µl DNA 
 
 0, 5 µl Klenow Fragment (3'-5´ exo-) 
A master mix was made and the mix distributed to micro tubes together with the 
DNA. The tubes were put in the micro cycler at 94C for 2 minutes and after that 
put directly on ice for 2 minutes. Next 0, 5 µl Klenow Fragment (3'-5´ exo-) was 
added and the micro tubes were put in the cycler again: 37C for 60 minutes 94C 
for 2 minutes and after that directly put on ice for 2 minutes. Thereafter 0, 5 µl 
Klenow Fragment (3'-5´ exo-) was added and the tubes once again put in the 
cycler: 37C for 60 minutes and 75C for 10 minutes. The labelled D A was 
stored in the micro cycler at        over the night until the next morning when the 
random DNA-amplification was done.  
Random amplification of labelled DNA 
PCR master mix:  
 5 µl buffer (10X) 
 5 µl MgCl2 (25 mM) 
 1 µl dNTP (10 mM each) 
 4 µl FR20 (10 mM) (ALLANDER et al., 2005) 
 0,5 µl AmpliTaq Gold polymerase (5U/µl) 
 32 µl H2O 
+ 2.5 µl template 
 
For each labelled DNA aliquote 5 separate reactions were run from the Culex 
samples and the Monsonia samples. From the Anopheles samples only 4 reactions 
were run due to pipette problems.   
  
The used PCR-program was:  
95C for 12 minutes; 40 cycles of - 95C for 30 seconds, 58C for 30seconds, 
72C for 90 seconds; and a final 10 minutes elongation step at 72C 
5 µl PCR product was run on 1, 5% gel with etidium bromide (130V, 90 mA for 
20 minutes) 
 
The remaining PCR product was stored at -20C until sent to Sweden.  
Sources of errors 
 The pipettes in the lab were not calibrated and therefore the volumes were 
not right at all times. 
 Unknown numbers of power breakdowns during the incubation times 
which disturbed the temperatures.  
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RESULTS 
ELISA 
The tested animals were adults and the majority of them were females. The sero-
prevalence varied between the different farms, but animals from all species on 
every farm were tested positive for SBV-antibodies in the “ID screen 
Schmallenberg virus competition Multi-species” ELISA-kit. 10 animals from each 
species that first tested positive when the serum was undiluted all tested negative 
when the serum was diluted 1:100, 1:200 and 1:400.  
Cattle 
Cattles from two different farms were sampled. All of the tested animals, 36 from 
Cuácua – Rogerio and 43 from Nicoadala – Amed, were sero-positive for SBV-
antibodies. In the tables below, table 5 and table 6, the prevalence’s from the two 
farms are presented. The average prevalence was 100% among the cattle. The 
results in table 1 are from ELISA-reactions with undiluted serum. 
Tabell 5 
Species  Farm Positive  
Bos indicus Cuácua – 
Rogerio 
100% (36/36) 
Bos indicus Nicoadala – 
Amed 
100% (43/43) 
Table 5 shows the proportion of animals positive for SBV-antibodies among the 
tested cattle.  
When the serum was diluted 1:2 times 100% of the tested animals were positive. 
When the serum was diluted 1:4 93% of the animals tested positive and 3% tested 
negative. In dilution 1:8 87% of the tested animals were positive and 13% were 
negative for SBV-antibodies. In table 5 the sero-prevalencein diluted serum is 
presented.  
Tabell 6 
Cattle Dilution 
1:2 
Dilution 
1:4 
Dilution 
1:8 
Positive 100% 
(30/30) 
93% 
(28/30) 
87% 
(26/30) 
Intermediate  3% 
(1/30) 
 
Negative 0% 
(0/30) 
3% 
(1/30) 
13% 
(4/30) 
Table 6 shows the sero-prevalence for SBV-antibodies in diluted serum from 
cattle 
Sheep 
Sheep from 5 different farms were tested for SBV-antibodies. The tested animals 
were all adults, mostly females. Sheep from all farms were tested sero-positive for 
SBV-antibodies. The prevalence ranged from 43% to 97% in the different farms, 
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with an average prevalence of 63%.  In the tables below, table 7 and table 8, the 
prevalence’s from the farms are presented. The results in table 7 are from ELISA-
reactions with undiluted serum. 
Tabell 7 
Species Farm  Positive  Negative  
Sheep Cuácua – 
Rogerio 
69% 
(24/35) 
31% 
(11/35) 
Sheep Mopeia 
south 
97% 
(33/34) 
3% 
(1/34) 
Sheep Nicuadala 
- Amed 
43% 
(3/7) 
57% 
(4/7) 
Sheep Nicuadala 
- Mucelo 
56% 
(19/34) 
44% 
(15/34) 
Sheep Quelimane 
- Padeiro 
49% 
(17/35) 
51% 
(18/35) 
Table 7 shows the proportion of animals positive and negative for SBV-antibodies 
among the tested sheep 
When the serum was diluted 1:2 86% of the animals were positive and 14% were 
negative. In dilution 1:4 82% of the animals were tested positive and 18% tested 
positive. When the serum was diluted 1:8 71% of the animals were positive for 
SBV-antibodies and 18% were negative. The sero-prevalence 
Tabell 8 
Sheep Dilution 
1:2 
Dilution 
1:4 
Dilution 
1:8 
Positive 86% 
(24/28) 
82% 
(23/28) 
71% 
(20/28) 
Intermediate   11% 
(3/28) 
Negative 14% 
(4/28) 
18% 
(5/28) 
18% 
(5/28) 
Table 8 shows the sero-prevalence for SBV-antibodies in diluted serum from 
sheep 
Goat  
Goats from 6 farms were tested for SBV-antibodies. All of the tested animals 
were adults and most of them were females. There were animals which tested 
positive on all of the farms. The prevalence ranged from 72% to 100% with an 
average prevalence of    . In the tables below, the prevalence’s from the farms 
are presented. The results in table 9 are from ELISA-reactions with undiluted 
serum.   
Tabell 9 
Species Farm Positive  Negative  
Goat Cuácua - 
Rogerio 
89% 
(25/28) 
11% 
(3/28) 
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Goat Deda 100% 
(3/3) 
0% (0/3) 
Goat Nicuadala 
- Amed 
74% 
(23/31) 
26% 
(8/31) 
Goat Nicuadala 
- Mingano 
90% 
(19/21) 
19% 
(2/21) 
Goat Quelimane 
- Dona 
Ana 
72% 
(23/32) 
28% 
(9/32) 
Goat Quelimane 
- Padeiro 
81% 
(21/26) 
19% 
(5/26) 
Table 9 shows the proportion of animals positive and negative for SBV-antibodies 
among the tested goats   
Serum from 30 goats was diluted 1:2, 1:4 and 1:8. When the serum was diluted 
1:2 97% of the tested goats were positive for SBV-antibodies and 3% were 
negative. In dilution 1:4 93% were positive and 7% were negative. When the 
serum was diluted 1:8 87% of the goats were positive and 13% were negative for 
SBV-antibodies. The results in table 10 present the sero-prevalence in diluted 
serum. 
Tabell 10 
Goat Dilution 
1:2 
Dilution 
1:4 
Dilution 
1:8 
Positive  97% 
(29/30) 
93% 
(28/30) 
87% 
(26/30) 
Intermediate    
Negative 3% 
(1/30) 
7% 
(2/30) 
13% 
(4/30) 
Table 10 shows the sero-prevalence for SBV-antibodies in diluted serum from 
goat 
Gel electrophoresis 
The figure below, figure 2, shows the result from the gel electrophoresis done on 
the PCR-products from the 3 mosquito pooles. From the left: ladder 100 base 
pairs, Culex 1, Culex 2, Culex 3, Culex 4, Culex 5, Monsonia 1, Monsonia 2, 
Monsonia 3, Monsonia 4, Monsonia 5,  and Anopheles 1, Anopheles 2, Anopheles 
3, Anopheles 4. The molecular size of the smears from all samples is around 100 
bp.  
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Figure 2: Gel electrophoresis on PCR-products from mosquito samples. From the 
left: ladder 100 bp, C1, C2, C3, C4, C5, M1, M2, M3, M4, M5, A1, A2, A3 and 
A4.  
 
Answers to questionnaire 
Chimuara  
Date: 2013-09-25  
Cuacua – Rogerio S: 17.79748 E: 035.41442 
 
 130 sheep and 137 goats 
 History of disease: During 2013 2 adult goats and 7 adult sheep have died, 
all of them females. 5 juvenile males and 9 juvenile females died during 
the wet season. The farmer believed that these deaths among the juveniles 
were due to too little milk and too damp environment. 5-10 sheep about 10 
months old died from assumed snakebites.  
 The animals are not vaccinated.  
Chimuara  
Date: 2013-09-26  
Cuacua- Rogerio S: 17.90069 E: 03541220 
 
 The number of cattle and water buffalos is unknown.   
 History of disease: 1 adult female cattle and 2 adult buffalos have died 
during 2013 with unknown symptoms.  
 The cattle were vaccinated against rift valley fever in July 2012 and 
Lumpy skin disease 2013.  
Deda 
Date: 2013-09-27 
S: 17.98278 E: 03576248 
 
 120 goats and 28 cattle 
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 History of disease: during 2013 20 juvenile goats died with neurological 
symptoms and 5 goats have aborted. Among cattle there have been 2 
abortions.  
 No malformations in neonatals or foetuses have been seen.  
 
Mopeia South 
Date: 2013-09-27 
S: 17.89602 E: 035.74150 
 
 64 sheep  
 History of disease: 1 adult sheep died during partus.  
 No abortions.  
 A few juvenile labs have died due to trampling from cattle.  
 
Quelimane – Padeiro 
Date: 2013-09-30 
S: 17.82279 E: 03692272 
 58 cattle, 64 sheep and 36 goats.  
 History of disease: A few goats and sheep have had a fever (no 
thermometer was used) during the rainy season and were treated for 
trypanosomiasis.  
 5 juvenile goats and sheep have had diarrhoea.  
 No abortions and no malformations among newborns. 
Nicoadala – Mucelo 
Date: 2013-09-30 
S: 17.70626 E:036.89647 
 
 The farm has 223 sheep over three months and an unknown number of 
lambs less than 3 months. The farm also has cattle.  
 History of disease: 5 sheep and 4 cattle have had late abortions but no 
malformed newborns. The farmer believes that they aborted due to a poor 
food supply. The farm has had some problems with tympanism in cattle 
and sheep. 3 cattle, 7 months old died with some kind of symptoms from 
their mouth. Some adult sheep died during rainy season due to diarrhoea. 
No deaths in neonatals.  
 The cattle were vaccinated against lumpy skin disease this year and rift 
valley fever another year.  
Nicoadala- Amed 
Date: 2013-10-01 
S: 17.60097 E: 036.82723 
 108 goats and 10 sheep.  
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 History of disease: Problems with laminitis. No abortions. Some juveniles 
died due to trampling. Some deaths which farmer believes are due to tick 
born diseases since they have not used tick repellents this year. Some 
deaths due to attack by stray dogs.  
Nicoadala- Amed 
Date: 2013-10-01 
S: 17.60421 E: 03682723 
 
 536 cattle 
 History of disease: Problems with laminitis. During rain period some 
animals gets pneumonia. Sometimes there are problems with diarrhoea and 
sometimes with poor food supply. In both cattle and sheep more young 
animals die during the rainy season and more adults during dry season.  
 The cattle were vaccinated this year against lumpy skin disease and last 
year against rift valley fever.  
Nicoadala – Mingano 
Date: 2013-10-02 
S: 17.80573 E: 037.13612 
 
 42 goats and 82 cattle 
 History of disease: Some deaths among the cattle due to supposed tick 
borne infections. During the last month there have been 4 early abortions 
among goats and 2 among cattle. No malformations among neonatals. 
Some neonatals have died presumably due to lack of milk from the dam.   
 Vaccination of cattle against rift valley fever last year and this year for 
lumpy skin disease and trypanosomiasis. 
 
Quelimane - Dona ana 
Date: 2013-10-02 
S: 17.83348 E: 036.93911 
 70 goats and 29 cattle 
 History of disease: possible tympanism in 2 adults and 17 juveniles 
between 1 and 2 months.  Symptoms: swollen abdomen and salivation. 
One cow aborted last week, no abortions in goats. The cattle are 
vaccinated against something, the animal keeper is uncertain against what.  
DISCUSSION  
Schmallenberg virus 
A vast majority of the tested animals from each farm tested positive for SBV-
antibodies. The highest prevalence for SBV-antibodies was among the cattle, 
100% of the tested animals were positive. The average prevalence among 
22 
 
sheep and goats were 63% (43-97%) respectively 84% (72-100%). The 
epidemiology, with a high sero-prevalence on the positive farms, seen among 
the ruminants in Zambezia is corresponding with the patterns of the serology 
surveys conducted in Europe (ELBERS et al., 2012, MEROC et al., 2013). 
 
Even when the serum was diluted 1:2, 1:4 and 1:8 a majority of the tested 
animals were positive. Although equality in epidemiologic pattern and the 
positive results with diluted serum make a true positive result for SBV-
antibodies more probable, they do not exclude the possibility of false positive 
results due to cross-reacting virus in the same area.  
 
Since SBV was recently discovered and since there are not any known viruses 
from the Simbu sero-group in Europe no studies on cross-reactivity with SBV 
have been conducted. Consequently, it is not known nor proven if there are 
any viruses that could cross-react with the SBV. In 2007 NAKOUNE´ 
YANDOKO et al., stated that although there are serological immunoassays 
available for detection of some Orthobunyaviruses, cross-reactions in the tests 
are common. This does impair the interpretation of the positive SBV-ELISA 
results in the study. It is of common opinion that Shamonda virus and 
Sathuperi virus, members of the Simbu sero-group, are the closest relatives of 
the Schmallenberg virus (YANASE et al., 2012). Both Sathuperi virus and 
Shamonda virus have been isolated in Africa both in midgets and in a broad 
spectrum of ruminants (CAUSEY et al., 1972, LEE et al., 1979). Hence a 
cross-reaction with the Schmallenberg virus and Sathuperi virus or Shamonda 
virus is not unlikely.  
 
To ascertain that SBV truly exist in Moçambique, further studies ought to be 
done, aiming to detect the virus and to determine the sequence of the genome. 
This could be done e.g. using PCR, cellculture isolation of virus or 
metagenomic methods. It is also of great interest to collect Culicoides midgets 
in areas with SBV-positive animals to see if they carry the virus.  
 
Since SBV-antibodies have been found in the wild cervid population in 
Belgium and it is expected that other wild ruminants are susceptive to the 
virus (LINDEN et al., 2012), this must be considered a conceivable reservoir 
and maybe the origin of the SBV. 
   
The possibility that SBV evolved in Africa should also be considered. 
Satupheri virus and Shamonda virus are distributed in the same geographic 
areas, in Africa and Asia, and have the same hosts (ruminants) and the same 
vectors (Culicoides midgets) as SBV. Thus, SBV might be the result of a co-
infection with Satupheri virus and Shamonda virus (YANASE et al., 2012). If 
Africa is the origin of SBV it is also interesting to study its transmission route 
to Europe, especially since SBV emerged in the very same area were Blue 
tongue virus emerged 2009. This makes it likely that there is an unknown 
pathway for virus to Europe.   
 
The fact that none of the interviewed farmers had experienced any problems 
neither with malformed or with misshaped newborns nor with abortions 
among the pregnant dams is conspicuous. When according to the serology; 
SBV is highly existent among their livestock. If assuming that the results are 
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true and that SBV exist in the area, its wide distribution might be the 
explanation to why it is not noticed – if the virus is endemic in an area, the 
majority of the animals will be infected before they breed, making the disease 
pass unnoticed. The weak symptoms or total absence of symptoms among 
adult animals also makes the disease hard to detect and might lead to an 
underreporting of the disease. Clearance of virus before birth in confirmed 
infected lambs have been recorded, which also make the disease pass 
unnoticed (MEROC et al., 2013). According to this, SBV is of little 
importance in areas where it is endemic.  
 
Metagenomics 
According to the fact that a good smear for metagenomic use of a PCR 
product is expected to be ranging between 200bp to 20kb, the received smear 
is too short to be optimal. The smear ranging around 100 bp, shows that the 
material is partly degraded. This might be the result of remaining rests of 
inhibitory substances from the mosquitoes affecting the PCR. Due to the fact 
that the metagenomic analyzes are not yet done, it is not possible to evaluate 
the final result.  
CONCLUSION 
Neutralizing antibodies for SBV are frequently occurring among cattle, sheep 
and goats in the Zambezia province, Moçambique. If it truly are SBV anti-
bodies the virus is endemic in the area and consequently not a problem. 
Further studies on this topic should be done aiming to isolate the virus and 
confirm the result.  It is of great interest to determine the origin of the virus 
and possibly find its transmission rout to Europe.  
Since Moçambique has been appointed to be a hot spot for emerging 
infectious diseases the viral metagenomic results are of great interest.  
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